Skip to main content

Beneficial ownership — 13D / 13G

87,281 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Neeraj Agrawal AMPL Amplitude, Inc. 13G/A 10.9% 2y
Strategic Value Investors LP MRBK Meridian Corp 13G/A 5.8% 2y
M3 Funds, LLC SWKHL SWK Holdings Corp 13G/A 6.16% 2y
K2 HealthVentures Equity Trust LLC MTEM Molecular Templates, Inc. 13G/A 9.99% 2y
Omega Fund VI, L.P. LXEO Lexeo Therapeutics, Inc. 13G 8.1% 2y
GenScript Biotech Corporation LEGN Legend Biotech Corp 13G/A 47.99% 2y
GLAZER CAPITAL, LLC VMCAF Valuence Merger Corp. I 13G/A 11.28% 2y
Andrew Shape SWAG Stran & Company, Inc. 13G/A 19.2% 2y
AQR CAPITAL MANAGEMENT LLC KYCH Keyarch Acquisition Corporation Ordinary Shares 13G/A 1.48% 2y
Granahan Investment Management, LLC MGNI Magnite, Inc. 13G/A 4.88% 2y
Point72 Asset Management, L.P. VTGN Vistagen Therapeutics, Inc. 13G/A 3% 2y
Invenomic Capital Management LP LEXX Lexaria Bioscience Corp. 13G/A 7.12% 2y
RIVERNORTH CAPITAL MANAGEMENT, LLC GCTS GCT Semiconductor Holding, Inc. 13G 9.52% 2y
T. Rowe Price Investment Management, Inc. CSW Csw Industrials, Inc. 13G 7.3% 2y
BIOTECHNOLOGY VALUE FUND L P TYRA Tyra Biosciences, Inc. 13G/A 6.4% 2y
Nan Shan Life Insurance Co., Ltd. KREF KKR Real Estate Finance Trust Inc. 13G/A 4.44% 2y
FPR PARTNERS LLC VISN Vistance Networks, Inc. 13G/A 8.8% 2y
PRICE T ROWE ASSOCIATES INC /MD/ RARE Ultragenyx Pharmaceutical Inc. 13G/A 4.2% 2y
AMERIPRISE FINANCIAL INC STVN Stevanato Group S.p.A. 13G/A 3.22% 2y
First Trust Capital Management L.P. ROSS Ross Acquisition Corp II 13G 9.85% 2y
McIntyre Dee Ann UFCS United Fire Group Inc 13G/A 11.9% 2y
CVI Investments, Inc. EVFM Evofem Biosciences, Inc. 13G/A 0.9% 2y
Gleb Budman BLZE Backblaze, Inc. 13G/A 4.8% 2y
Brookfield Oaktree Holdings, LLC ECDA ECD Automotive Design, Inc. 13G/A 1.14% 2y
(VOLUNTARY) Kim A. Rivers TRLV Trulieve Cannabis Corp. 13G/A 9.55% 2y
Cormorant Asset Management, LP JBIO Jade Biosciences, Inc. 13G/A 4.38% 2y
T. Rowe Price Investment Management, Inc. AMPL Amplitude, Inc. 13G 8.2% 2y
Fort Baker Capital Management LP OKLO Oklo Inc. 13G 5.85% 2y
Brookfield Oaktree Holdings, LLC EMAT Evolution Metals & Technologies Corp. 13G/A 0% 2y
Radcliffe Capital Management, L.P. NKGN NKGen Biotech, Inc. Common Stock 13G/A 0% 2y
First Trust Capital Management L.P. GAQ Generation Asia I Acquisition Limited Class A Ordinary Shares 13G 9.95% 2y
Werner Capital LLC ENFN Enfusion, Inc. 13G/A 5.04% 2y
BIOTECHNOLOGY VALUE FUND L P PYXS Pyxis Oncology, Inc. 13G/A 0% 2y
Harvey Partners, LLC MTRX Matrix Service Co 13G/A 5.2% 2y
ARMISTICE CAPITAL, LLC RKTO Rocket One Inc. 13G/A 4.99% 2y
Atlas Merchant Capital LLC IPVF InterPrivate III Financial Partners Inc. 13G/A 0% 2y
First Trust Capital Management L.P. PLAO Patria Latin American Opportunity Acquisition Corp. Class A Ordinary Shares 13G 9.93% 2y
Par Sanda SRG Seritage Growth Properties 13G/A 4.11% 2y
Atalaya Capital Management LP GAQ Generation Asia I Acquisition Limited Class A Ordinary Shares 13G/A 6.9% 2y
ARMISTICE CAPITAL, LLC AGIO Agios Pharmaceuticals, Inc. 13G/A 6.31% 2y
Nathan Leight YTRA Yatra Online, Inc. 13G/A 5.59% 2y
PERCEPTIVE ADVISORS LLC VRCA Verrica Pharmaceuticals Inc. 13G/A 16.9% 2y
Sandia Investment Management LP OPTX Syntec Optics Holdings, Inc. 13G/A 0.93% 2y
Lincoln Park Capital Fund, LLC XFOR X4 Pharmaceuticals, Inc 13G/A 0.95% 2y
AWM Investment Company, Inc. IPWR Ideal Power Inc. 13G/A 9.99% 2y
Ares Trading SA PGEN Precigen, Inc. 13G/A 8.3% 2y
RA CAPITAL MANAGEMENT, L.P. NSTG NanoString Technologies, Inc. 13G/A 0% 2y
Radcliffe Capital Management, L.P. LIVB LIV Capital Acquisition Corp. II Class A Ordinary Shares 13G/A 0% 2y
EVR Research LP SSTI Soundthinking, Inc. 13G/A 4.8% 2y
T. Rowe Price Investment Management, Inc. AVY Avery Dennison Corp 13G 5.3% 2y